ATS American Thoracic Society
Recent Abstracts

Quality of Life in Respiratory Illness Questionnaire

Name of Questionnaire

Quality-of-Life for Respiratory Illness Questionnaire (QOL-RIQ)


Disease-specific quality of life measure designed for patients with reversible and fixed airway obstruction. Patients are asked how much of a problem each item has been during the past year.


A. Maille, A. Kaptein, C. Koning, A. Zwinderman


A. Maille
Department of Psychiatry
University of Leiden, P.O. Box 1251
2340 BG Oegstgeest
The Netherlands

Cost & availibility

Contact A Maille for permission for use.



Time to complete

Not reported.

Number of items


Domains & categories (#)

7 domains

Name of domains & categories

Domains: breathing problems (9 items); physical problems (9 items); emotions (9 items); situations triggering or enhancing breathing problems (7 items); daily and domestic activities (10 items); social activities, relationships and sexuality (7 items); general activities (4 items)

Scaling of items

7-point Likert-type


Domain and total scale scores


  • Test-retest/reproducibility: Not reported
  • Internal consistency: Reported 1


Reported; clinical indices of disease severity (dyspnea, frequency of attacks, severity, general practitioner visits, absence from work)1,2


Not reported

Minimally important difference

Not determined.

Research use

Not reported

Clinical use

Not reported


English, Dutch


  1. Maille AR, Koning CJM, Kaptein AA. Developing a quality-of-life questionnaire for patients with respiratory illness. Monaldi Arch Chest Dis 1994;49:76-8.
  2. Maille AR, Koning CJM, Zwinderman AH, Willems LNA, Dijkman JH, Kaptein AA. The development of the "Quality-of-Life for Respiratory Illness Questionnaire (QOL-RIQ)": a disease-specific quality-of-life questionaire for patients with mild to moderate chronic non-specific lung disease. Respiratory Med 1997;91:297-309.

Date of information

September 2001

Copyright © 2007 American Thoracic Society · Web Site Requirements
Questions or comments? Contact Us.